Mostrando 4 resultados de: 4
Subtipo de publicación
Article(4)
Publisher
PLoS Neglected Tropical Diseases(2)
Acta Tropica(1)
Revista da Sociedade Brasileira de Medicina Tropical(1)
Área temáticas
Enfermedades(4)
Medicina forense; incidencia de enfermedades(3)
Medicina y salud(2)
Farmacología y terapéutica(1)
Fisiología humana(1)
Origen
scopus(4)
2<sup>nd</sup> Brazilian Consensus on Chagas disease, 2015
ArticleAbstract: Chagas disease is a neglected chronic condition with a high burden of morbidity and mortality. It haPalabras claves:Brazil, Chagas disease, consensus, control, diagnosis, epidemiology, Health Care, TreatmentAutores:Alves R.V., Andrade G.M.Q., Campos D.E., Cardoso A.V., Carvalho N.B., Chiari E., Correia D., Coura J.R., Da Costa V.M., De Almeida E.A., De Oliveira Junior W., De Paoli de Carvalho Britto C.F., De Rezende J.M., De Sousa A.S., Dias J.C.P., E Silva R.A., Fernando Abad-Franch, Ferreira A.W., Fragata Filho A.A., Gontijo E.D., Hasslochermoreno A.M., Jansen A.M., Lima M.M., Luquetti A.O., Maria Da Cunha Galvão L., Marin-Neto J.A., Marques D.S.D.O., Melo J.R.D.C., Moreira E.F., Oliveira S.M., Pinto A.Y.D.N., Pinto F.S., Ramos A.N., Rassi A., Rassi Junior A., Santos S.E., Shikanai-Yasuda M.A., Silva E.L., Silveira A.C., Torres R.M., Valente S.A.D.S., Valente V.D.C., Vivaldini S.M., Xavier S.S.Fuentes:scopusDevelopment of Peptide-Based Lineage-Specific Serology for Chronic Chagas Disease: Geographical and Clinical Distribution of Epitope Recognition
ArticleAbstract: Background:Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a serioPalabras claves:Autores:Bhattacharyya T., Carrasco H.J., Diosque P., Falconar A.K.I., García L., Guhl F., Jaime Alfredo Costales, Lewis M.D., Litvinov S.V., Luquetti A.O., Mario J. Grijalva, Messenger L.A., Miles M.A., Ramírez J.D., Tran T.T.Fuentes:scopusSerological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease.
ArticleAbstract: Chagas disease, caused by the protozoan Trypanosoma cruzi, affects more than 6 million people worldwPalabras claves:3973, antigens, Chagas disease, Chemotherapy response, Chronic infection, F29, hsp70, InfYnity multiplexed ELISA, KMP11, PFR2, TRYPANOSOMA CRUZIAutores:Abril M., Alonso-Padillaid J., Benítez C., Casellas A., Chatelain E., de Noya B.A., Esteva M., Gascón J., Gómez I., Granjon E., Guhl F., Hasslochermoreno A.M., Jorge T.A., Longhi S.A., López M.C., Luquetti A.O., Mario J. Grijalva, Méndez S., Noya O., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Sanz S., Schijman A.G., Sosa-Estani S., Thomas M.C., Torrico F., Viotti R., Zrein M.Fuentes:scopusTarget product profile for a test for the early assessment of treatment efficacy in chagas disease patients: An expert consensus
ArticleAbstract:Palabras claves:Autores:Abril M., Almeida I.C., Alonso-Padillaid J., Angheben A., Carmen Thomas M., Chatelain E., de Noya B.A., Esteva M., Gascón J., Guhl F., Hasslochermoreno A.M., Jorge T.A., López M.C., Luquetti A.O., Mario J. Grijalva, Noya O., Picado A., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Schijman A.G., Sosa-Estani S., Torrico F., Zreinid M.Fuentes:scopus